Financial reports
10-Q
2024 Q1
Quarterly report
14 Feb 24
10-K
2023 FY
Annual report
22 Dec 23
10-Q
2023 Q3
Quarterly report
14 Aug 23
10-Q
2023 Q2
Quarterly report
11 May 23
10-Q
2023 FY
Quarterly report
14 Feb 23
10-K
2022 FY
Annual report
29 Dec 22
10-Q
2022 Q3
Quarterly report
15 Aug 22
10-Q
2022 Q2
Quarterly report
16 May 22
10-Q
2022 Q1
Quarterly report
14 Feb 22
10-K
2021 FY
Annual report
6 Dec 21
Current reports
8-K
Termination of a Material Definitive Agreement
7 May 24
8-K
Entry into a Material Definitive Agreement
8 Dec 23
8-K
Entry into a Material Definitive Agreement
31 Jul 23
8-K
AmeriCann Reports Record Fiscal Year-End and Quarterly Financial Results
9 Jan 23
8-K
AmeriCann Reports Record Quarter and Fiscal Year-End Financial Results
8 Dec 21
8-K
AmeriCann Announces a 300% Increase in Annual Revenue
18 Nov 21
8-K
AmeriCann Announces Nearly 300% Increase in Quarterly Revenue from Comparable Quarter in 2020
6 Jul 21
8-K
AmeriCann Announces Record Breaking Quarterly Revenue
6 Apr 21
8-K
Submission of Matters to a Vote of Security Holders
1 Mar 21
8-K
Other Events
19 Feb 21
Registration and prospectus
S-1/A
IPO registration (amended)
11 Oct 19
S-1
IPO registration
27 Sep 19
D
$4M in debt / options, sold $4M, 1 investor
8 Aug 19
POS AM
Prospectus update (post-effective amendment)
23 Jul 19
POS AM
Prospectus update (post-effective amendment)
1 Jul 19
424B3
Prospectus supplement
13 Jun 19
POS AM
Prospectus update (post-effective amendment)
31 May 19
S-1
IPO registration
18 Sep 18
D
$12.73K in options, sold $12.73K, 27 investors
18 Jul 18
D
$10M in equity, sold $172.41K, 1 investor
18 May 18
Other
EFFECT
Notice of effectiveness
16 Oct 19
CORRESP
Correspondence with SEC
11 Oct 19
UPLOAD
Letter from SEC
8 Oct 19
EFFECT
Notice of effectiveness
2 Aug 19
EFFECT
Notice of effectiveness
9 Jul 19
EFFECT
Notice of effectiveness
6 Jun 19
EFFECT
Notice of effectiveness
28 Sep 18
CORRESP
Correspondence with SEC
26 Sep 18
UPLOAD
Letter from SEC
26 Sep 18
EFFECT
Notice of effectiveness
10 May 18